It’s been highly impressive to watch the speed at which Christina Coughlin and her team have expedited AVA6103 and AVA6207 since I joined the board of #AVCT a little over 6 months ago. The pre|CISION technology which sits behind these drugs is nothing short of groundbreaking.
